Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Abdullah Jameel Aburiziza. (2020) Primary Juvenile Sjögren’s Syndrome in a 3-Year-Old Pediatric Female Patient: Diagnostic Role of Salivary Gland Ultrasonography: Case Report. Open Access Rheumatology: Research and Reviews 12, pages 73-78.
Read now
Read now
Lara A. Aqrawi, Janicke Liaaen Jensen, Siren Fromreide, Hilde Kanli Galtung & Kathrine Skarstein. (2020) Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren’s syndrome. Autoimmunity 53:6, pages 333-343.
Read now
Read now
Kathrine Skarstein, Janicke Liaaen Jensen, Hilde Galtung, Roland Jonsson, Karl Brokstad & Lara A. Aqrawi. (2019) Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren’s syndrome. Autoimmunity 52:7-8, pages 242-250.
Read now
Read now
Kathrine Skarstein, Lara A. Aqrawi, Gunnvor Øijordsbakken, Roland Jonsson & Janicke Liaaen Jensen. (2016) Adipose tissue is prominent in salivary glands of Sjögren’s syndrome patients and appears to influence the microenvironment in these organs. Autoimmunity 49:5, pages 338-346.
Read now
Read now
Amy Donate, Alexandria Voigt & Cuong Q Nguyen. (2014) The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms. Expert Review of Clinical Immunology 10:4, pages 469-481.
Read now
Read now
Lara A. Aqrawi, Karl A. Brokstad, Kjerstin Jakobsen, Roland Jonsson & Kathrine Skarstein. (2012) Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome. Autoimmunity 45:7, pages 547-555.
Read now
Read now
Donald R Staines, Ekua W Brenu & Sonya Marshall-Gradisnik. (2009) Postulated vasoactive neuropeptide immunopathology affecting the blood–brain/blood–spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?. Neuropsychiatric Disease and Treatment 5, pages 81-89.
Read now
Read now
Miguel Cordero-Coma, Fahd Anzaar, Lucia Sobrin & C. Stephen Foster. (2007) Systemic Immunomodulatory Therapy in Severe Dry Eye Secondary to Inflammation. Ocular Immunology and Inflammation 15:2, pages 99-104.
Read now
Read now
Chris T Derk. (2005) Sjogren’s syndrome: models of pathogenesis and treatment targets. Expert Opinion on Therapeutic Patents 15:11, pages 1587-1594.
Read now
Read now
Articles from other publishers (61)
Yuyang Sun, Viviane Nascimento Da Conceicao, Arun Chauhan, Pramod Sukumaran, Pooja Chauhan, Julian L. Ambrus, Arjan Vissink, Frans G. M. Kroese, Madesh Muniswamy, Bibhuti B. Mishra & Brij B. Singh. (2023)
Targeting alarmin release reverses Sjogren's syndrome phenotype by revitalizing Ca
2+
signalling
. Clinical and Translational Medicine 13:4.
Crossref
Crossref
Clara Chivasso, Claudia D’Agostino, Dorian Parisis, Muhammad S. Soyfoo & Christine Delporte. (2023) Involvement of aquaporin 5 in Sjögren’s syndrome. Autoimmunity Reviews 22:3, pages 103268.
Crossref
Crossref
Harim T. dos Santos, Kihoon Nam, Diana Gil, Venkata Yellepeddi & Olga J. Baker. (2023) Current experimental methods to investigate the impact of specialized pro-resolving lipid mediators on Sjögren’s syndrome. Frontiers in Immunology 13.
Crossref
Crossref
A.M. Malkova & Y. Shoenfeld. (2023) Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. Autoimmunity Reviews 22:1, pages 103230.
Crossref
Crossref
A.M. Malkova & Y. Shoenfeld. (2022) Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. Autoimmunity Reviews, pages 103231.
Crossref
Crossref
Pantea Mohammadi, Mahvash Hesari, Maryam Chalabi, Farhad Salari & Fatemeh Khademi. (2022) An overview of immune checkpoint therapy in autoimmune diseases. International Immunopharmacology 107, pages 108647.
Crossref
Crossref
Saba Asam, Georgiana Neag, Onorina Berardicurti, David Gardner & Francesca Barone. (2021) The role of stroma and epithelial cells in primary Sjögren’s syndrome. Rheumatology 60:8, pages 3503-3512.
Crossref
Crossref
Cordula DahlmannCordula Dahlmann. 2019. Sicca-Syndrom. Sicca-Syndrom
1
17
.
Alexandria Voigt, Katherine Bohn, Sukesh Sukumaran, Carol M. Stewart, Indraneel Bhattacharya & Cuong Q. Nguyen. (2018) Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis. Clinical Immunology 192, pages 58-67.
Crossref
Crossref
Ching-Shuen Wang & Olga J. Baker. (2018) The G-Protein–Coupled Receptor ALX/Fpr2 Regulates Adaptive Immune Responses in Mouse Submandibular Glands. The American Journal of Pathology 188:7, pages 1555-1562.
Crossref
Crossref
Arun Wanchoo, Alexandria Voigt, Sukesh Sukumaran, Carol M. Stewart, Indraneel Bhattacharya & Cuong Q. Nguyen. (2017) Single-cell analysis reveals sexually dimorphic repertoires of Interferon-γ and IL-17A producing T cells in salivary glands of Sjögren’s syndrome mice. Scientific Reports 7:1.
Crossref
Crossref
Anthony J. Bron, Cintia S. de Paiva, Sunil K. Chauhan, Stefano Bonini, Eric E. Gabison, Sandeep Jain, Erich Knop, Maria Markoulli, Yoko Ogawa, Victor Perez, Yuichi Uchino, Norihiko Yokoi, Driss Zoukhri & David A. Sullivan. (2017) TFOS DEWS II pathophysiology report. The Ocular Surface 15:3, pages 438-510.
Crossref
Crossref
Lida Esfandiary, Nirupama Gupta, Alexandria Voigt, Arun Wanchoo, Edward K. L. Chan, Sukesh Sukumaran & Cuong Q. Nguyen. (2016) Single-cell antibody nanowells: a novel technology in detecting anti-SSA/Ro60- and anti-SSB/La autoantibody-producing cells in peripheral blood of rheumatic disease patients. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Robert I. Fox & Carla M. Fox. (2016) Sj?gren Syndrome. Rheumatic Disease Clinics of North America 42:3, pages 519-530.
Crossref
Crossref
Maureen Rischmueller, Joanna Tieu & Susan Lester. (2016) Primary Sjögren's syndrome. Best Practice & Research Clinical Rheumatology 30:1, pages 189-220.
Crossref
Crossref
R.I. Fox & C.M. Fox. 2016. Sjogren's Syndrome. Sjogren's Syndrome
241
261
.
Sabrina Ceeraz, Elizabeth C Nowak, Christopher M Burns & Randolph J Noelle. (2014) Immune checkpoint receptors in regulating immune reactivity in rheumatic disease. Arthritis Research & Therapy 16:5.
Crossref
Crossref
Sahana Vishwanath, Sandra Everett, Long Shen, Kishore Malyavantham, Lakshmanan Suresh & Julian L. Ambrus Jr.. (2014) Xerophthalmia of Sjogren's Syndrome Diagnosed with Anti-Salivary Gland Protein 1 Antibodies. Case Reports in Ophthalmology 5:2, pages 186-189.
Crossref
Crossref
L A Aqrawi, M Kvarnström, K A Brokstad, R Jonsson, K Skarstein & M Wahren-Herlenius. (2014) Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjögren's syndrome. Clinical and Experimental Immunology 177:1, pages 244-252.
Crossref
Crossref
Yune-Jung ParkSeung-Ah YooWan-Uk Kim. (2014) Role of Endoplasmic Reticulum Stress in Rheumatoid Arthritis Pathogenesis. Journal of Korean Medical Science 29:1, pages 2.
Crossref
Crossref
Clio P. Mavragani, George E. Fragoulis & Haralampos M. Moutsopoulos. 2014. The Autoimmune Diseases. The Autoimmune Diseases
495
510
.
L A Aqrawi, K Skarstein, G Øijordsbakken & K A Brokstad. (2013) Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome. Clinical and Experimental Immunology 172:2, pages 228-237.
Crossref
Crossref
Cuong Q. Nguyen, Adebola O. Ogunniyi, Afife Karabiyik & J. Christopher Love. (2013) Single-Cell Analysis Reveals Isotype-Specific Autoreactive B Cell Repertoires in Sjögren’s Syndrome. PLoS ONE 8:3, pages e58127.
Crossref
Crossref
Long Shen, Lakshmanan Suresh, Matthew Lindemann, Jingxiu Xuan, Przemek Kowal, Kishore Malyavantham & Julian L. AmbrusJr.Jr.. (2012) Novel autoantibodies in Sjogren's syndrome. Clinical Immunology 145:3, pages 251-255.
Crossref
Crossref
Athanasios G. Tzioufas, Ioanna P. Tatouli & Haralampos M. Moutsopoulos. (2012) Autoantibodies in Sjögren's syndrome: Clinical presentation and regulatory mechanisms. La Presse Médicale 41:9, pages e451-e460.
Crossref
Crossref
Biji T. Kurien, Andrew Porter, Yaser Dorri, Saqib Iqbal, Anil D'Souza, Anil Singh, Sima Asfa, Marc Cartellieri, Kristen Mathias, Hiroyuki Matsumoto, Michael Bachmann, Kenneth Hensley & R. Hal Scofield. (2011) Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice. Free Radical Biology and Medicine 50:10, pages 1222-1233.
Crossref
Crossref
Toshiharu Hayashi. (2011) Dysfunction of Lacrimal and Salivary Glands in Sjögren′s Syndrome: Nonimmunologic Injury in Preinflammatory Phase and Mouse Model. BioMed Research International 2011:1.
Crossref
Crossref
Kazuhisa Nozawa, Minoru Satoh, Seunghee Cha, Yoshinari Takasaki & Edward K. L. Chan. 2012. Sjögren’s Syndrome. Sjögren’s Syndrome
111
132
.
Robert I. Fox. 2012. Sjögren’s Syndrome. Sjögren’s Syndrome
285
316
.
Thomas Mandl & Lennart Jacobsson. 2012. Sjögren’s Syndrome. Sjögren’s Syndrome
303
319
.
George E. Tzelepis, Clio P. Mavragani & Haralampos M. Moutsopoulos. 2012. Sjögren’s Syndrome. Sjögren’s Syndrome
185
194
.
OSKAR HAMMAR, BODIL OHLSSON, PER WOLLMER & THOMAS MANDL. (2010) Impaired Gastric Emptying in Primary Sjögren’s Syndrome. The Journal of Rheumatology 37:11, pages 2313-2318.
Crossref
Crossref
D. S?ne, F.-J. Authier, Z. Amoura, P. Cacoub & J.-P. Lefaucheur. (2010) Neuropathie des petites fibres?: approche diagnostique et traitement, et place de son association au syndrome de Gougerot-Sj?gren primaire. La Revue de M?decine Interne 31:10, pages 677-684.
Crossref
Crossref
T. Mandl, O. Hammar, E. Theander, P. Wollmer & B. Ohlsson. (2010) Autonomic nervous dysfunction development in patients with primary Sjogren's syndrome: a follow-up study. Rheumatology 49:6, pages 1101-1106.
Crossref
Crossref
Ljudmila Stojanovich. (2009) Autonomic dysfunction in autoimmune rheumatic disease. Autoimmunity Reviews 8:7, pages 569-572.
Crossref
Crossref
Long Shen, Lakshmanan Suresh, Hong Li, Chongjie Zhang, Vijay Kumar, Oleh Pankewycz & Julian L. AmbrusJr.Jr.. (2009) IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans. Clinical Immunology 130:3, pages 304-312.
Crossref
Crossref
Carol M Stewart & Kathleen Berg. (2008) Oral manifestations of Sjögren's syndrome. Future Rheumatology 3:6, pages 543-558.
Crossref
Crossref
Vanessa Schegg, Monique Vogel, Svetlana Didichenko, Michael B. Stadler, Zsuzsanna Beleznay, Stephan Gadola, Christine Sengupta, Beda M. Stadler & Sylvia M. Miescher. (2008) Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R. Biologicals 36:4, pages 213-222.
Crossref
Crossref
Carol Stewart, Seunghee Cha, Robert M. Caudle, Kathleen Berg & Joseph Katz. (2008) Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren’s syndrome. Rheumatology International 28:8, pages 771-776.
Crossref
Crossref
Cuong Q. Nguyen, Min H. Hu, Yi Li, Carol Stewart & Ammon B. Peck. (2008) Salivary gland tissue expression of interleukin‐23 and interleukin‐17 in Sjögren's syndrome: Findings in humans and mice. Arthritis & Rheumatism 58:3, pages 734-743.
Crossref
Crossref
D. R. Staines, E. W. Brenu & S. Marshall-Gradisnik. (2009) Postulated Role of Vasoactive Neuropeptide‐Related Immunopathology of the Blood Brain Barrier and Virchow‐Robin Spaces in the Aetiology of Neurological‐Related Conditions. Mediators of Inflammation 2008:1.
Crossref
Crossref
Joop P van de Merwe. (2007) Interstitial cystitis and systemic autoimmune diseases. Nature Clinical Practice Urology 4:9, pages 484-491.
Crossref
Crossref
Cuong Q. Nguyen, Hyuna Kim, Janet G. Cornelius & Ammon B. Peck. (2007)
Development of Sjögren’s Syndrome in Nonobese Diabetic-Derived Autoimmune-Prone C57BL/6.NOD-
Aec1Aec2
Mice Is Dependent on Complement Component-3
. The Journal of Immunology 179:4, pages 2318-2329.
Crossref
Crossref
W G Law, B YH Thong, T Umapathi & H H Chng. (2016) Letter to the Editor. Lupus 15:12, pages 899-900.
Crossref
Crossref
L. J. Dawson, P. C. Fox & P. M. Smith. (2006) Sjögrens syndrome—the non-apoptotic model of glandular hypofunction. Rheumatology 45:7, pages 792-798.
Crossref
Crossref
Driss Zoukhri. (2006) Effect of inflammation on lacrimal gland function. Experimental Eye Research 82:5, pages 885-898.
Crossref
Crossref
L. J. Dawson, J. Stanbury, N. Venn, B. Hasdimir, S. N. Rogers & P. M. Smith. (2006) Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis & Rheumatism 54:4, pages 1165-1173.
Crossref
Crossref
SALLY A. WATERMAN, MICHAEL W. JACKSON & TOM P. GORDON. 2006. The Autoimmune Diseases. The Autoimmune Diseases
217
236
.
R. Hal Scofield, Sima Asfa, David Obeso, Roland Jonsson & Biji T. Kurien. (2005) Immunization with Short Peptides from the 60-kDa Ro Antigen Recapitulates the Serological and Pathological Findings as well as the Salivary Gland Dysfunction of Sjögren’s Syndrome. The Journal of Immunology 175:12, pages 8409-8414.
Crossref
Crossref
Luke Dawson, Andrew Tobin, Peter Smith & Tom Gordon. (2005) Antimuscarinic antibodies in Sjögren's syndrome: Where are we, and where are we going?. Arthritis & Rheumatism 52:10, pages 2984-2995.
Crossref
Crossref
Kazuo Uchida, Yoichi Akita, Keitaro Matsuo, Shigeyoshi Fujiwara, Atsuko Nakagawa, Yoshiaki Kazaoka, Hiroshi Hachiya, Yoshiyuki Naganawa, Ichiro Oh‐iwa, Kiyoshi Ohura, Shinsuke Saga, Tatsushi Kawai, Yoshinari Matsumoto, Kazuo Shimozato & Ken‐ichi Kozaki. (2005) Identification of specific autoantigens in Sjögren's syndrome by SEREX. Immunology 116:1, pages 53-63.
Crossref
Crossref
M. D. Mignogna, S. Fedele, L. Lo Russo, L. Lo Muzio & A. Wolff. (2004) Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia. Journal of Oral Pathology & Medicine 34:1, pages 1-6.
Crossref
Crossref
Donald R. Staines. (2005) Therapeutic and preventive interventions for postulated vasoactive neuropeptide autoimmune fatigue-related disorders. Medical Hypotheses 65:4, pages 797-803.
Crossref
Crossref
Fang Wang, Michael W. Jackson, Vicki Maughan, Dana Cavill, Anthony J. Smith, Sally A. Waterman & Tom P. Gordon. (2004) Passive transfer of Sjögren's syndrome IgG produces the pathophysiology of overactive bladder. Arthritis & Rheumatism 50:11, pages 3637-3645.
Crossref
Crossref
Yuki Hayashi, Naozumi Ishimaru, Rieko Arakaki, Shin‐ichi Tsukumo, Hitomi Fukui, Kenji Kishihara, Hiroshi Shiota, Koji Yasutomo & Yoshio Hayashi. (2004) Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti‐CD4 monoclonal antibody. Arthritis & Rheumatism 50:9, pages 2903-2910.
Crossref
Crossref
Juehua Gao, Seunghee Cha, Roland Jonsson, Jeffrey Opalko & Ammon B. Peck. (2004) Detection of anti–type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay. Arthritis & Rheumatism 50:8, pages 2615-2621.
Crossref
Crossref
Frédéric Lavie, Corinne Miceli‐Richard, Jeanine Quillard, Sophie Roux, Philippe Leclerc & Xavier Mariette. (2004) Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. The Journal of Pathology 202:4, pages 496-502.
Crossref
Crossref
Dana Cavill, Sally A. Waterman & Tom P. Gordon. (2003) Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission. Arthritis & Rheumatism 48:12, pages 3597-3602.
Crossref
Crossref
Sue Lester, Debashish Danda, Dana Cavill, Kevin Pile, Sarah Downie‐Doyle & Maureen Rischmueller. (2003) Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome. Arthritis & Rheumatism 48:11, pages 3293-3294.
Crossref
Crossref
Roland Jonsson, Tom P. Gordon & Yrjö T. Konttinen. (2003) Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome. Current Rheumatology Reports 5:4, pages 311-316.
Crossref
Crossref
Sally A. Waterman, Dimitra Beroukas, Jenny Hiscock, Roland Jonsson & Tom P. Gordon. (2003) Aquaporins in primary Sjögren's syndrome: Comment on the articles by Steinfeld et al. Arthritis & Rheumatism 48:4, pages 1167-1168.
Crossref
Crossref